Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression

Anzhou Xia(China XD Group (China)), Xiaoli Wu(Huaian First People’s Hospital)
Oncology Reports
July 20, 2018
Cited by 24


Related Papers